Table 6 Summary of overall findings including HER2/neu reactions in the 125 cases
From: Systematic assessment of HER2/neu in gynecologic neoplasms, an institutional experience
Overall information | HER2/neu | |||||
|---|---|---|---|---|---|---|
Groups | Neoplasm | Median age | n | % | POS (n) | POS (%) |
Group I | CCCA | 54 | 11 | 8.8 % | 3 | 27.3 % |
Group II | SCA | 58 | 45 | 36.0 % | 5 | 11.1 % |
Group III | ENAdCA | 61.5 | 28 | 22.4 % | 0 | 0.0 % |
Group IV | MxSEAdCA | 65 | 26 | 20.8 % | 1 | 3.8 % |
Group V | Other | 54 | 15 | 12.0 % | 1 | 6.7 % |